• Thumbnail for Baricitinib
    Baricitinib, sold under the brand name Olumiant among others, is an immunomodulatory medication used for the treatment of rheumatoid arthritis, alopecia...
    43 KB (3,613 words) - 02:13, 16 July 2024
  • Thumbnail for Incyte
    (tafasitamab-cxix) , Opzelura (Ruxolitinib), Tabrecta (capmatinib), Olumiant (Baricitinib), and Iclusig (ponatinib). In 2013, Novartis acquired Incyte's c-Met...
    11 KB (763 words) - 16:06, 3 June 2024
  • Thumbnail for Remdesivir
    FDA issued an emergency use authorization (EUA) for the combination of baricitinib with remdesivir, for the treatment of suspected or laboratory confirmed...
    113 KB (9,807 words) - 01:49, 16 July 2024
  • Thumbnail for Alopecia areata
    In June 2022, the U.S. Food and Drug Administration (FDA) authorized baricitinib, a Janus kinase (JAK) inhibitor, for the treatment of severe alopecia...
    43 KB (4,204 words) - 14:20, 13 July 2024
  • Administration (FDA) requires a boxed warning for the JAK inhibitors tofacitinib, baricitinib, and upadacitinib to warn about the risks of serious heart-related events...
    36 KB (2,981 words) - 17:57, 23 June 2024
  • alopecia spironolactone and flutamide. In June 2022, the FDA authorized baricitinib for the treatment of severe alopecia areata. Minoxidil, applied topically...
    68 KB (7,160 words) - 18:52, 24 February 2024
  • crizotinib, daclatasvir, sofosbuvir, afatinib, axitinib, brigatinib, baricitinib, cabozantinib, dasatinib, neratinib, eltrombopag, ibrutinib, lenvatinib...
    5 KB (232 words) - 10:23, 8 March 2024
  • Thumbnail for COVID-19 pandemic
    Later that month, the WHO recommended the rheumatoid arthritis drug Baricitinib for severe or critical patients. It also recommended the monoclonal antibody...
    367 KB (32,614 words) - 01:18, 14 July 2024
  • metaplasia with myelofibrosis and vitiligo. Examples are tofacitinib, baricitinib, upadacitinib and filgotinib. In 2014 researchers discovered that oral...
    9 KB (974 words) - 14:46, 22 June 2024
  • "Bloomberg", February 9, 2017 Jackson, Mandy. "ACR Notebook: Lilly's Baricitinib Differentiates On Pain, Ironwood's Duzallo Progress, Corbus Nears Phase...
    3 KB (156 words) - 10:21, 6 July 2024